Search Results  for 'ALNEV.PA'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Neovacs SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) a subsidiary of Truffle Capital is a biotechnolog...

16 May 2016 GlobalData 43 $300.00

Wright Investors Service Comprehensive Report for Neovacs SA

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 May 2016 Wright Reports 54 $75.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a biotechnology company that engages in develo...

17 Mar 2016 GlobalData 48 $300.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a biotechnology company that engages in develo...

11 Dec 2015 GlobalData 45 $300.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a biotechnology company that engages in ...

04 Aug 2015 GlobalData 37 $125.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a biotechnology company. The company dev...

03 Jun 2015 GlobalData 37 $125.00

NEOVACS - PRINTEMPS À PARIS

Neovacs has refocused onto IFNα-Kinoid in lupus (SLE). The planning to start a Phase IIb lupus study in mid-2015 is now well ...

23 Apr 2015 Edison Investment Research 3 $10.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a biotechnology company. The company dev...

23 Mar 2015 GlobalData 36 $125.00

NEOVACS

Neovacs is now focused on IFNα-Kinoid in lupus (SLE) and plans to start Phase II lupus studies in mid-2015. The Phase IIb rhe...

27 Jan 2015 Edison Investment Research 10 $10.00